Patients with advanced liver disease often face difficult choices about treatment. One common procedure is the transjugular intrahepatic portosystemic shunt, or TIPS. Doctors use this to treat fluid buildup in the belly or bleeding from the esophagus. Before surgery, doctors try to predict if a patient will survive. They often use the Model for End-Stage Liver Disease, or MELD, score. This meta-analysis compared MELD scores with a new tool called the Freiburg index of post-TIPS survival, or FIPS. The goal was to see which tool better predicts death within 90 days.
The researchers looked at data from 5,180 patients. These patients had TIPS for either ascites or gastroesophageal bleeding. The study combined results from multiple sources to get a clear picture. They measured how well each score could separate patients who died from those who survived. The main measure was the area under the curve, or AUC. An AUC of 0.5 means the score is no better than a coin toss. An AUC of 1.0 means perfect prediction.
For patients with ascites, the standard MELD score had an AUC of 0.703. Adding sodium to the calculation, known as MELD-Na, gave an AUC of 0.699. A newer version called MELD 3.0 improved this to 0.790. The new FIPS score performed best in this group with an AUC of 0.821. For patients with bleeding, the MELD score had an AUC of 0.827. MELD-Na dropped to 0.781. MELD 3.0 reached 0.797. The FIPS score was lower at 0.689 for this group. The study noted that differences between these groups were not statistically significant.
The study did not report safety concerns or adverse events. This is common in meta-analyses that focus on prediction models rather than drug treatments. The researchers examined sources of variation in the data but did not detail them. This means some differences between studies might remain unclear. The funding source was not reported. This is standard for many published abstracts.
People should not overreact to these numbers. A single meta-analysis cannot change how every hospital operates. The results suggest that MELD scores work well for predicting early death in patients with bleeding. For patients with fluid buildup, MELD 3.0 or FIPS might offer better prediction. However, doctors must consider each patient individually. These tools are aids, not replacements for clinical judgment. Patients should discuss their specific risk with their care team. This research helps doctors choose the right tool for the right situation.